EA000048B1 - Применение олигосахарида и аспирина для лечения тромбоэболических заболеваний, фармацевтическая композиция, способ лечения - Google Patents

Применение олигосахарида и аспирина для лечения тромбоэболических заболеваний, фармацевтическая композиция, способ лечения Download PDF

Info

Publication number
EA000048B1
EA000048B1 EA199700025A EA199700025A EA000048B1 EA 000048 B1 EA000048 B1 EA 000048B1 EA 199700025 A EA199700025 A EA 199700025A EA 199700025 A EA199700025 A EA 199700025A EA 000048 B1 EA000048 B1 EA 000048B1
Authority
EA
Eurasian Patent Office
Prior art keywords
oligosaccharide
aspirin
sulfo
sulfamino
deoxy
Prior art date
Application number
EA199700025A
Other languages
English (en)
Russian (ru)
Other versions
EA199700025A1 (ru
Inventor
Роже Кариу
Якобус Стикема
Original Assignee
Акцо Нобель Н.В.
Санофи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акцо Нобель Н.В., Санофи filed Critical Акцо Нобель Н.В.
Publication of EA199700025A1 publication Critical patent/EA199700025A1/ru
Publication of EA000048B1 publication Critical patent/EA000048B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EA199700025A 1997-03-10 1997-03-13 Применение олигосахарида и аспирина для лечения тромбоэболических заболеваний, фармацевтическая композиция, способ лечения EA000048B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002199642A CA2199642C (fr) 1997-03-10 1997-03-10 Compositions associant l'aspirine et un oligosaccharide anti-xa et utilisation d'un oligosaccharide anti-xa facultativement associe a l'aspirine
AU16319/97A AU698456B2 (en) 1997-03-10 1997-03-14 Compositions containing an association of aspirin and an anti-Xa oligosaccharide and use of anti-Xa oligosaccharide optionally in combination with aspirin
BR9701313A BR9701313A (pt) 1997-03-10 1997-03-17 Composições que contêm uma associação de aspririna e um oligossacarídeo anti-xa e uso de um olissacarídeo anti-xa opicionalmente em combinação com aspirina

Publications (2)

Publication Number Publication Date
EA199700025A1 EA199700025A1 (ru) 1997-12-30
EA000048B1 true EA000048B1 (ru) 1998-04-30

Family

ID=27152254

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199700025A EA000048B1 (ru) 1997-03-10 1997-03-13 Применение олигосахарида и аспирина для лечения тромбоэболических заболеваний, фармацевтическая композиция, способ лечения

Country Status (4)

Country Link
AU (1) AU698456B2 (fr)
BR (1) BR9701313A (fr)
CA (1) CA2199642C (fr)
EA (1) EA000048B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794412B1 (en) * 1999-03-11 2004-09-21 Bristol-Myers Squibb Pharma Company Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin
UA80399C2 (en) * 2001-11-13 2007-09-25 Glaxo Group Ltd Use of specific dose of fondaparinux sodium for the treatment of acs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563351C (en) * 1982-01-15 2003-06-19 Glaxo Group Limited Synthesis of oligosaccharides
FR2564468B1 (fr) * 1984-05-16 1994-12-23 Choay Sa Nouveaux oligosaccharides, leur preparation par voie de synthese et leurs applications biologiques

Also Published As

Publication number Publication date
AU1631997A (en) 1998-09-17
CA2199642C (fr) 2001-05-08
BR9701313A (pt) 1998-11-17
CA2199642A1 (fr) 1998-09-10
EA199700025A1 (ru) 1997-12-30
AU698456B2 (en) 1998-10-29

Similar Documents

Publication Publication Date Title
RU2184547C2 (ru) Новые соединения действующих начал, содержащих клопидогрел, и антитромбическое средство
NO323739B1 (no) Preparater for behandling og forebygging av arteriell trombose og anvendelse av en faktor Xa inhibitor kombinert med et antiblodplateaggregeringsmiddel
US20080113960A1 (en) Combinations comprising a low molecular weight thrombin inhibitor and a prodrug of a low molecular weight thrombin inhibitor
Herbert et al. SR123781A, a synthetic heparin mimetic
MXPA03010493A (es) Uso de sulodexido para el tratamiento de enfermedad de intestino inflamado.
US6518244B2 (en) Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof
CZ20014665A3 (cs) Prostředek s obsahem heparinu se střední molekulovou hmotností
De Teresa et al. Interaction between anticoagulants and contraceptives: an unsuspected finding.
EA000048B1 (ru) Применение олигосахарида и аспирина для лечения тромбоэболических заболеваний, фармацевтическая композиция, способ лечения
JP3169343B2 (ja) アスピリンおよび抗−Ｘａオリゴ糖の組合せを含有する組成物ならびにアスピリンと任意的に組み合わせた抗−Ｘａオリゴ糖の使用
KR100231978B1 (ko) 아스피린 회합체 및 안티-Xa 올리고사카라이드를 함유하는 조성물과 아스피린 결합물내 안티-XA 올리고사카라이드의 용도
US20060122151A1 (en) Composition containing an association of aspirin and an anti-Xa oligosaccharide and use of an anti-Xa oligosaccharide optionally in combination with aspirin
Rothlin et al. Platelet inhibitors versus anticoagulants for prevention of aorto-coronary bypass graft occlusion
WO2003013423A2 (fr) Agent antithrombotique
MXPA97001943A (en) Compositions containing an acetilsalicilic acid association and an anti-xa oligosacarid and use of an anti-xa oligosacaride optionally in combination with acetilsalicil acid
WO2012158003A1 (fr) Nouvel inhibiteur du facteur xii
JP2005505537A (ja) 低分子量ヘパリンと低分子量デルマタン硫酸とを含む抗血栓組成物
JP2004507562A (ja) 抗血栓性組成物
MX2015002646A (es) Otamixaban para uso en el tratamiento de sindrome coronario agudo sin elevacion de st en pacientes programados para ser sometidos a injerto de bypass de arteria coronaria.
CA2293081A1 (fr) Traitement medicamenteux de la restenose
Perianu Clinical safety profile of cefodizime
AU2002248566A1 (en) Combinations of heparin cofactor II agonist and platelet IIB/IIIA antagonist, and uses thereof
JPH11100322A (ja) 新規虚血・再灌流障害抑制剤
ZA200108544B (en) A pharmaceutical formulation comprising a low molecular weight thrombin inhibitor and its prodrug.
MXPA01010512A (es) Formulacion farmaceutica que comprende inhibidor de trombina de bajo peso molecular y su profarmaco

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ KZ KG MD TJ TM

PD4A Registration of transfer of a eurasian patent in accordance with the succession in title
PC4A Registration of transfer of a eurasian patent by assignment
TC4A Change in name of a patent proprietor in a eurasian patent

Designated state(s): AM AZ KZ KG MD TJ TM

MK4A Patent expired

Designated state(s): BY RU